• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 3 filed by new insider E15 Fund Ii, Lp

    10/1/21 8:13:51 PM ET
    $DEH
    Business Services
    Finance
    Get the next $DEH alert in real time by email
    SEC FORM 3 SEC Form 3
    FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0104
    Estimated average burden
    hours per response: 0.5
    1. Name and Address of Reporting Person*
    E15 Fund II, LP

    (Last) (First) (Middle)
    C/O VICARIOUS SURGICAL INC.
    78 FOURTH AVENUE

    (Street)
    WALTHAM MA 02451

    (City) (State) (Zip)
    2. Date of Event Requiring Statement (Month/Day/Year)
    09/17/2021
    3. Issuer Name and Ticker or Trading Symbol
    Vicarious Surgical Inc. [ RBOT ]
    4. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    5. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Beneficially Owned
    1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
    Table II - Derivative Securities Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
    Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    Remarks:
    Exhibit 24.1 - Power of Attorney
    No securities are beneficially owned.
    /s/ June Morris, Attorney-in-Fact 09/21/2021
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $DEH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $DEH

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $DEH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by D8 Holdings Corp.

      SC 13G - Vicarious Surgical Inc. (0001812173) (Subject)

      9/30/21 5:27:18 PM ET
      $DEH
      Business Services
      Finance
    • SEC Form SC 13D filed by D8 Holdings Corp.

      SC 13D - Vicarious Surgical Inc. (0001812173) (Subject)

      9/30/21 5:25:24 PM ET
      $DEH
      Business Services
      Finance
    • SEC Form SC 13D filed by D8 Holdings Corp.

      SC 13D - Vicarious Surgical Inc. (0001812173) (Subject)

      9/28/21 5:02:17 PM ET
      $DEH
      Business Services
      Finance

    $DEH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4: Khosla Ventures V, L.P. bought $3,333,340 worth of shares (333,334 units at $10.00) (Amendment)

      4/A - Vicarious Surgical Inc. (0001812173) (Issuer)

      10/18/21 6:49:35 PM ET
      $DEH
      Business Services
      Finance
    • SEC Form 3: New insider Khosla Ventures Seed C, L.P. claimed ownership of 20,622,788 shares (Amendment)

      3/A - Vicarious Surgical Inc. (0001812173) (Issuer)

      10/18/21 6:47:08 PM ET
      $DEH
      Business Services
      Finance
    • SEC Form 3 filed by new insider Patnaik Shrikant

      3 - Vicarious Surgical Inc. (0001812173) (Issuer)

      10/1/21 8:14:50 PM ET
      $DEH
      Business Services
      Finance

    $DEH
    SEC Filings

    See more
    • D8 Holdings Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Vicarious Surgical Inc. (0001812173) (Filer)

      10/20/21 4:10:10 PM ET
      $DEH
      Business Services
      Finance
    • SEC Form S-1 filed by D8 Holdings Corp.

      S-1 - Vicarious Surgical Inc. (0001812173) (Filer)

      10/15/21 4:09:48 PM ET
      $DEH
      Business Services
      Finance
    • D8 Holdings Corp. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year (Amendment)

      8-K/A - Vicarious Surgical Inc. (0001812173) (Filer)

      9/23/21 4:07:29 PM ET
      $DEH
      Business Services
      Finance

    $DEH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Vicarious Surgical Business Combination Approved; Stock to Begin Trading on the New York Stock Exchange as "RBOT"

      Vicarious Surgical to debut on NYSE as a disruptive next-generation surgical robotics company Approximately $220 million in gross cash proceeds to catalyze advancement of Vicarious Surgical's robotic technology, clinical programs, and strategic business initiatives Combined company to trade on NYSE under ticker symbol "RBOT" Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE:RBOT, RBOT WS))), a next-generation robotics technology company seeking to improve both cost and efficiency of surgical procedures as well as patient outcomes, today announced that the shareholders of D8 Holdings Corp. ("D8") (NYSE:DEH, DEH, DEH WS))), have approved the previously announced bus

      9/15/21 4:50:00 PM ET
      $BDX
      $DEH
      $NFH
      Medical/Dental Instruments
      Health Care
      Business Services
      Finance
    • Vicarious Surgical Inc. and D8 Holdings Corp. Announce Additional PIPE Commitments

      Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company"), a next-generation robotics technology company seeking to improve both cost and efficiency of surgical procedures as well as patient outcomes, and D8 Holdings Corp. ("D8") (NYSE:DEH), a special purpose acquisition company, today announced that they have secured $27 million in additional commitments for a private placement of common stock ("PIPE") in support of their business combination transaction, bringing the aggregate amount of PIPE commitments to $142 million, and the total anticipated gross proceeds of the business combination to approximately $487 million (assuming no redemptions). The additional commitments ensure that

      9/9/21 8:34:00 PM ET
      $BDX
      $DEH
      $NFH
      Medical/Dental Instruments
      Health Care
      Business Services
      Finance
    • Vicarious Surgical CEO Adam Sachs to Present at Surgical Disruptive Technology Summit

      WALTHAM, Mass., May 27, 2021 /PRNewswire/ -- Vicarious Surgical Inc. ("Vicarious" or "Vicarious Surgical" or the "Company"), a next-generation robotics technology company seeking to improve both cost and efficiency of surgical procedures as well as patient outcomes, today announced that Adam Sachs, Co-Founder and Chief Executive Officer of Vicarious Surgical, will participate in a panel discussion on the future of surgical robots at the Surgical Disruptive Technology Summit in Houston, Texas on June 4, 2021. Presentation Details Title:     Surgical Robotics: The Next 5 YearsD

      5/27/21 4:07:00 PM ET
      $DEH
      Business Services
      Finance